Biomarkers in exhaled breath condensate: a review of collection, processing and analysis
- 1 September 2008
- journal article
- review article
- Published by IOP Publishing in Journal of Breath Research
- Vol. 2 (3), 037004
- https://doi.org/10.1088/1752-7155/2/3/037004
Abstract
Exhaled breath condensate (EBC) is a potential rich source for countless biomarkers that can provide valuable information about respiratory as well as systemic diseases. EBC has been studied in a variety of diseases including allergic rhinitis, asthma, chronic obstructive lung disease, cystic fibrosis, lung cancer, and obstructive sleep apnea syndrome. Although numerous biomarkers have been discovered and studied in EBC, the methods of collection and biomarker detection have not been fully standardized. While leaving standardization methods up to individual labs for the present time is optimal for the continued discovery of new biomarkers in EBC, this decreases the reproducibility and generalizability of the findings. In this review we will discuss specific biomarkers studied in specific diseases as well as some of the related technical issues including collection, processing and analysis.Keywords
This publication has 138 references indexed in Scilit:
- Exhaled nitric oxide in asthma: progress since the introduction of standardized methodologyJournal of Breath Research, 2008
- A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensateRapid Communications in Mass Spectrometry, 2008
- Exhaled Breath Condensate: An OverviewImmunology and Allergy Clinics of North America, 2007
- Exhaled breath condensate pH in infants and children with acute and recurrent wheezy bronchitisPediatric Pulmonology, 2007
- Increased alveolar nitric oxide concentration and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosisThorax, 2007
- Detection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead ArrayMediators of Inflammation, 2006
- Flunisolide Decreases Exhaled Nitric Oxide and Nitrotyrosine Levels in Asthmatic ChildrenMediators of Inflammation, 2006
- Reactive nitrogen species in the respiratory tractEuropean Journal of Pharmacology, 2006
- Cytokines in exhaled breath condensate of children with asthma and cystic fibrosisAnnals of Allergy, Asthma & Immunology, 2006
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002